NASA’s Space Launch System rocket is rolled out to Launch Complex 39B ahead of the Artemis II moon mission on Jan. 17, 2026. ...

Previously lecanemab was only approved as an SC injection for maintenance dosing, following an initial 18 month IV phase.

Las Vegas, NV / Syndication Cloud / January 23, 2026 / ContrastConnect The American College of Radiology (ACR) and the ...

Japan’s Eisai and US biotech Biogen have announced that the US Food and Drug Administration (FDA) has accepted for review the ...

TogetherIV is the brain child of two Edina High School students, including one who gets monthly treatments for chronic ...

Discover how the NHS's new 5-minute super jab is set to revolutionize cancer treatment by targeting 15 different cancers with ...

Eisai and Biogen’s Supplemental Biologics License Application (sBLA) for Leqembi (lecanemab) subcutaneous autoinjector (SC-AI) has been accepted by the US FDA under Priority Review to treat early ...

LEQEMBI is currently approved in 53 countries and regions and is under regulatory review in 7 countries. In August 2025, the US FDA approved LEQEMBI IQLIK 360 mg for weekly subcutaneous maintenance ...

If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for initiation and maintenance dosing for this progressive, relentless disease ...

A, dubbed the “injection aunt” and accused of illegal medical practices targeting celebrities, claimed her husband was a ...

Lactated Ringers Injection Market to reach USD 2.9 Bn by 2036, driven by rising hospital admissions, increasing surgical ...

Learn how to self-administer SCIg at home for primary immunodeficiency. Tips on preparation, reducing pain, managing reactions, recordkeeping, and when to seek help.